-
Published 7/21/2026
Rudorf M, Baker T, Walker C, Bove N, Gruss DE, Roemmele L, Young AM, Larimore EE, Beers D, Langis G, Sahovey A, Fielman S, Anderson R, Beard D, Haessler K, Weinstein ZM, Fitzpatrick A, Weiss RD, Loukas V, Taylor JL, Chatterjee A, Cruz RS, Feldstein K, Hensel E, Calver K, Bridden C, Walley AY. Learning Collaboratives in the HEALing Communities Study: An Approach to Providing Training and Technical Assistance. Subst Use Addctn J. 2026 Jul 21; 29767342261460412. PMID: 42481077.
-
Published 7/14/2026
Harris MTH, Weinstein ZM, Walley AY. Treatments for Opioid Overdose-Reply. JAMA. 2026 Jul 14; 336(2):166. PMID: 42240979.
-
Published 4/18/2026
Weinstein ZM, Jadovich E, Drainoni ML, LaRochelle M, Yan S, Lee J, Bettano A, Beers D, Walley AY, Samet JH. Implementation of addiction consult services and bridge clinics in the HEALing communities study in Massachusetts. Drug Alcohol Depend. 2026 Jul 01; 284:113165. PMID: 42033894.
-
Published 4/17/2026
Cheng A, Weinstein ZM, Davoust M, Ventura AS, Magane KM, Theisen J, Blakemore S, Saitz R, Bazzi AR. "The Sky Didn't Fall": Patient and Clinician Experiences With Increased Buprenorphine Prescription Lengths During Pandemic-related Telehealth Expansion. J Addict Med. 2026 Apr 17. PMID: 41997587.
-
Published 4/16/2026
Weinstein ZM, Magane KM, Lodi S, Shea M, Chen CA, Doeleman D, Oot E, Bazzi AR, Davoust M, Ventura AS, Blakemore S, Saitz R. Impacts of personal or family COVID-19 infection on health-related quality of life among patients with opioid use disorder. J Subst Use. 2026 Apr 16. PMID: 42326891.